Prenetics Global【PRE】銘柄情報

Prenetics Global Ltd (PRE) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

21.63

( 4.54% )

買値

21.21

売値

22.17

出来高

348,521

20.34 日の範囲 22.22

6.88 52 週間の範囲 23.19

時価総額

363.999M

前日終値

20.69

始値

20.69

時刻

21.63

最終取引時間

05:10:05

財務取引量

US$ 7,533,104

VWAP

21.6145

平均取引量 (3 か月)

US$ 213,552

発行済株式数

16,828,437

配当利回り

PER

-8.21

1 株当たり利益 (EPS)

-2.68

歳入

92.39M

純利益

-37.71M

Prenetics Global Limited, a health sciences company, focuses on consumer health in Hong Kong and the United States. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is ... Prenetics Global Limited, a health sciences company, focuses on consumer health in Hong Kong and the United States. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide insights into health, wellness, and genetic predispositions. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong. 詳細を表示

セクター

Healthcare

業界

Medical Diagnostics & Screening

ウェブサイト

www.prenetics.com

本社

Quarry Bay, Hong Kong

設立

2026

Prenetics Global Ltd is listed in the Healthcare sector of the ナスダック市場 with ticker PRE. The last closing price for Prenetics Global was US$20.69. Over the last year, Prenetics Global shares have traded in a share price range of US$ 6.88 to US$ 23.19.

Prenetics Global currently has 16,828,437 shares in issue. The market capitalisation of Prenetics Global is US$364 million. Prenetics Global has a price to earnings ratio (PE ratio) of -8.21.

Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue

Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million, up 23.1% from IM8 revenue of $27.4 million...

Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion

Hudson Leogrande is the Founder and CEO of Comfrt — a multi-billion-dollar DTC brand projected to exceed $1...

Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership

Multi-year partnership lands as Prenetics’ IM8 raises full-year 2026 revenue guidance to $190 million to $210...

Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8

~ Two-decade veteran of premium consumer health, nutrition, and direct-to-consumer brands joins IM8 to support...

Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M

Prenetics records Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million, up 23.1% from IM8 revenue...

Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call

NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the...

Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership

NEW YORK and MIAMI, May 07, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or...

Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One

Partnership Extends IM8’s Mission Beyond Premium Nutrition to Address Malnutrition Among the World’s Most...

Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership

Giannis becomes the first NBA athlete shareholder in a NASDAQ-listed health and longevity brand, joining the...

Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation

IM8 90-Day Subscribers Unlock SuperPower Blood Testing for $49 — A 75% Saving on the Standard $199 Price.IM8...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	1.05	5.10204081633	20.58	21.515	18.12	298467	20.12285353	CS
4	4.07	23.1776765376	17.56	21.991	14	312171	18.60955695	CS
12	0.55	2.60910815939	21.08	23.19	14	218423	18.49458414	CS
26	5.98	38.2108626198	15.65	23.19	14	231482	18.30343183	CS
52	13.1	153.575615475	8.53	23.19	6.88	169572	16.31097022	CS
156	20.75	2357.95454545	0.88	23.19	0.2865	90115	11.43813047	CS
260	13.23	157.5	8.4	23.19	0.2865	143633	6.44226694	CS

PRE - Frequently Asked Questions (FAQ)

What is the current Prenetics Global Ltd share price?

The current share price of Prenetics Global Ltd is US$ 21.63

How many Prenetics Global Ltd shares are in issue?

Prenetics Global Ltd has 16,828,437 shares in issue

What is the market cap of Prenetics Global Ltd?

The market capitalisation of Prenetics Global Ltd is USD 364M

What is the 1 year trading range for Prenetics Global Ltd share price?

Prenetics Global Ltd has traded in the range of US$ 6.88 to US$ 23.19 during the past year

What is the PE ratio of Prenetics Global Ltd?

The price to earnings ratio of Prenetics Global Ltd is -8.21

What is the cash to sales ratio of Prenetics Global Ltd?

The cash to sales ratio of Prenetics Global Ltd is 3.62

What is the registered address of Prenetics Global Ltd?

The registered address for Prenetics Global Ltd is Unit 703-706, K11 Atelier King’s Road, Quarry Bay

What is the Prenetics Global Ltd website address?

The website address for Prenetics Global Ltd is www.prenetics.com

Which industry sector does Prenetics Global Ltd operate in?

Prenetics Global Ltd operates in the Medical Diagnostics & Screening sector

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Prenetics Global Ltd (PRE)

Prenetics Global Ltd (PRE) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

Prenetics Global Ltd について

PRE 最新ニュース

Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue

Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion

Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership

Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8

Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M

Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call

Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership

Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One

Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership

Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation

Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue

Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion

Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership

Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8

Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M

Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call

Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership

Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One

PRE - Frequently Asked Questions (FAQ)

PRE 取引

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

無料で登録してください:

広告を削除する